The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer

NCT00345059 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

84

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Advanced Non-Small Cell Lung Cancer

Interventions

DRUG: docetaxel
DRUG: vinorelbine
DRUG: gemcitabine
DRUG: capecitabine

Sponsor

National Cancer Institute, Naples